Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-07-26

FDA Approved: ELLENCE — Supplemental Application (Pharmacia & Upjohn Company LLC)

View source ↗

Summary

The FDA approved a supplemental application for Ellence (epirubicin hydrochloride) from Pharmacia & Upjohn Company LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ELLENCE (Epirubicin hydrochloride)

Snippet

SUPPL AP for ELLENCE (EPIRUBICIN HYDROCHLORIDE)